"Pure" severe aortic stenosis without concomitant valvular heart diseases: echocardiographic and pathophysiological features.
Aged
Aged, 80 and over
Aortic Valve
/ diagnostic imaging
Aortic Valve Stenosis
/ diagnostic imaging
Arterial Pressure
Asymptomatic Diseases
Cardiovascular Agents
/ therapeutic use
Cross-Sectional Studies
Echocardiography, Doppler
Female
Heart Valve Prosthesis Implantation
Humans
Hypertrophy, Left Ventricular
/ diagnostic imaging
Male
Middle Aged
Predictive Value of Tests
Pulmonary Arterial Hypertension
/ diagnostic imaging
Pulmonary Artery
/ diagnostic imaging
Reproducibility of Results
Retrospective Studies
Severity of Illness Index
Transcatheter Aortic Valve Replacement
Treatment Outcome
Ventricular Dysfunction, Left
/ diagnostic imaging
Ventricular Function, Left
Ventricular Remodeling
Diastolic dysfunction
Left ventricular hypertrophy
Pulmonary hypertension
Severe aortic valve stenosis
Transthoracic echocardiography
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
12
02
2020
accepted:
01
06
2020
pubmed:
6
6
2020
medline:
29
9
2020
entrez:
6
6
2020
Statut:
ppublish
Résumé
In echocardiography the severity of aortic stenosis (AS) is defined by effective orifice area (EOA), mean pressure gradient (mPG Patients (n = 306) with asymptomatic (n = 133) and symptomatic (n = 173) "pure" severe AS (mean age 78 ± 9.5 years) defined by indexed EOA < 0.6 cm In patients with "pure" AS according to current guidelines the presence of combined LVH, DD and PAH as accepted pathophysiological sequelae of severe AS cannot be confirmed. Probably, the detection of these secondary cardiac alterations might improve the diagnostic algorithm to avoid overestimation of AS severity.
Identifiants
pubmed: 32500398
doi: 10.1007/s10554-020-01907-4
pii: 10.1007/s10554-020-01907-4
pmc: PMC7497506
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1917-1929Références
Iung B, Vahanian A (2011) Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 8:162–172. https://doi.org/10.1038/nrcardio.2010.202
doi: 10.1038/nrcardio.2010.202
pubmed: 21263455
Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM et al (2013) Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 62(11):1002–1012
doi: 10.1016/j.jacc.2013.05.015
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739–2791
doi: 10.1093/eurheartj/ehx391
Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N (2010) Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function. Heart 96(18):1463–1468. https://doi.org/10.1136/hrt.2009.181982
doi: 10.1136/hrt.2009.181982
pubmed: 20813727
Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N (2008) Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 29(8):1043–1048
doi: 10.1093/eurheartj/ehm543
Ross J Jr, Braunwald E (1968) Aortic stenosis. Circulation 38(1):61–67
pubmed: 4894151
Gravanis MB, Robinson PH, Hertzler GL (1990) Hypertrophic cardiomyopathy evolving into a hypokinetic and dilated left ventricle: coronary embolization as a probable pathogenetic mechanism. Clin Cardiol 13(7):500–505
doi: 10.1002/clc.4960130714
Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the american society of echocardiography. J Am Soc Echocardiogr 32(1):1–64. https://doi.org/10.1016/j.echo.2018.06.004
doi: 10.1016/j.echo.2018.06.004
pubmed: 30282592
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39. https://doi.org/10.1016/j.echo.2014.10.003
doi: 10.1016/j.echo.2014.10.003
Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S et al (2017) Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 30(4):372–392. https://doi.org/10.1093/ehjci/jew335
doi: 10.1093/ehjci/jew335
Rader F, Sachdev E, Arsanjani R, Siegel RJ (2015) Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications. Am J Med 128(4):344–352. https://doi.org/10.1016/j.amjmed.2014.10.054
doi: 10.1016/j.amjmed.2014.10.054
pubmed: 25460869
Biner S, Rafique AM, Goykhman P, Morrissey RP, Naghi J, Siegel RJ (2010) Prognostic value of E/E' ratio in patients with unoperated severe aortic stenosis. JACC Cardiovasc Imaging 3:899–907. https://doi.org/10.1016/j.jcmg.2010.07.005
doi: 10.1016/j.jcmg.2010.07.005
pubmed: 20846623
Zuern CS, Eick C, Rizas K, Stoleriu C, Woernle B, Wildhirt S et al (2012) Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement. Clin Res Cardiol 101(2):81–88. https://doi.org/10.1007/s00392-011-0367-3
doi: 10.1007/s00392-011-0367-3
pubmed: 21969256
Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ Jr (2011) Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 141(6):1424–1430. https://doi.org/10.1016/j.jtcvs.2011.02.028
doi: 10.1016/j.jtcvs.2011.02.028
pubmed: 21596173
pmcid: 3244079
Barasch E, Kahn J, Petillo F, Pollack S, Rhee PD, Reicheck N (2014) Absence of left ventricular hypertrophy in severe isolated aortic stenosis and preserved left ventricular systolic function. J Heart Valve Dis 23(1):1–8
pubmed: 24779322
Hess OM, Villari B, Krayenbuehl HP (1993) Diastolic dysfunction in aortic stenosis. Circulation 87(5):73–76
Johnson, LW, Hapanowicz MB, Buonanno C, Bowser MA, Marvasti MA, Parker FB Jr (1988) Pulmonary hypertension in isolated aortic stenosis. Hemodynamic correlations and follow-up. J Thorac Cardiovasc Surg, 95(4): 603–607.
Ben-Dor I, Goldstein SA, Pichard AD, Satler LF, Maluenda G, Li Y et al (2011) Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 107(7):1046–1051. https://doi.org/10.1016/j.amjcard.2010.11.031
doi: 10.1016/j.amjcard.2010.11.031
pubmed: 21296325
Hagendorff A, Knebel F, Helfen A, Knierim J, Sinning C, Stöbe S et al (2019) Expert consensus document on the assessment of the severity of aortic valve stenosis by echocardiography to provide diagnostic conclusiveness by standardized verifiable documentation. Clin Res Cardiol. [Epub ahead of print]
Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the framingham heart study). Am J Cardiol 83(6):897–902
doi: 10.1016/S0002-9149(98)01064-9
Dahl CF, Allen MR, Urie PM, Hopkins PN (2008) Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med 6:34. https://doi.org/10.1186/1741-7015-6-34
doi: 10.1186/1741-7015-6-34
pubmed: 18990200
pmcid: 2585088
Lancellotti P, Magne J, Donal E, Davin L, O'Connor K, Rosca M et al (2012) Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol 59(3):235–243. https://doi.org/10.1016/j.jacc.2011.08.072
doi: 10.1016/j.jacc.2011.08.072
pubmed: 22240128
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 29(4):277–314. https://doi.org/10.1016/j.echo.2016.01.011
doi: 10.1016/j.echo.2016.01.011
pubmed: 27037982
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. the joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS). Eur Heart J 37(1):67–119
doi: 10.1093/eurheartj/ehv317
Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C et al (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3):319–324
doi: 10.1161/01.CIR.0000079171.43055.46
Eleid MF, Sorajja P, Michelena HI, Malouf JF, Scott CG, Pellikka PA (2013) Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation 128(16):1781–1789. https://doi.org/10.1161/CIRCULATIONAHA.113.003695
doi: 10.1161/CIRCULATIONAHA.113.003695
pubmed: 24048203
pmcid: 3929123
Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P (2007) Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115:2856–2864
doi: 10.1161/CIRCULATIONAHA.106.668681
deFilippi CR, Willett DL, Brickner E, Appleton CP, Yancy CW, Eichhorn EJ et al (1995) Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 75(2):191–194
doi: 10.1016/S0002-9149(00)80078-8
Schwammenthal E, Vered Z, Moshkowitz Y, Rabinowitz B, Ziskind Z, Smolinski AK et al (2001) Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest 119(6):1766–1777
doi: 10.1378/chest.119.6.1766
Tribouilloy C, Lévy F, Rusinaru D, Guéret P, Petit-Eisenmann H, Baleynaud S et al (2009) Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 53(20):1865–1873. https://doi.org/10.1016/j.jacc.2009.02.026
doi: 10.1016/j.jacc.2009.02.026
pubmed: 19442886
Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F et al (2006) Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo Severe Aortic Stenosis) study. Circulation 113(5):711–721
doi: 10.1161/CIRCULATIONAHA.105.557678
Clavel MA, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, Bergler-Klein J et al (2010) Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. J Am Soc Echocardiogr 23(4):380–386. https://doi.org/10.1016/j.echo.2010.02.002
doi: 10.1016/j.echo.2010.02.002
pubmed: 20362927
Seiler C, Jenni R (1996) Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors, and short-term follow up after aortic valve replacement. Heart 76:250–255
doi: 10.1136/hrt.76.3.250
Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50
doi: 10.1186/1532-429X-14-50
Yotti R, Bermejo J (2011) Left ventricular hypertrophy in aortic valve stenosis: friend or foe? Heart 97:269–271
doi: 10.1136/hrt.2010.205575
Duncan AI, Lowe BS, Garcia MJ, Xu M, Gillinov AM, Mihaljevic T et al (2008) Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 85(6):2030–2039. https://doi.org/10.1016/j.athoracsur.2008.02.075
doi: 10.1016/j.athoracsur.2008.02.075
pubmed: 18498815
Park JH, Marwick TH (2011) Use and limitations of E/e' to assess left ventricular filling pressure by echocardiography. J Cardiovasc Ultrasound 19(4):169–173. https://doi.org/10.4250/jcu.2011.19.4.169
doi: 10.4250/jcu.2011.19.4.169
pubmed: 22259658
pmcid: 3259539
Quere JP, Monin JL, Levy F, Petit H, Baleynaud S, Chauvel C et al (2006) Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation 113:1738–1744
doi: 10.1161/CIRCULATIONAHA.105.568824
Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A et al (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):55–66. https://doi.org/10.1016/j.jacc.2009.04.011
doi: 10.1016/j.jacc.2009.04.011
Silver K, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J et al (1993) Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J 125(1):146–150
doi: 10.1016/0002-8703(93)90067-J
Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R et al (2004) The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 148(4):649–654
doi: 10.1016/j.ahj.2004.04.029
Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63(6):493–505. https://doi.org/10.1016/j.jacc.2013.10.055
doi: 10.1016/j.jacc.2013.10.055
pubmed: 24291276
Généreux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA et al (2017) Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 38(45):3351–3358. https://doi.org/10.1093/eurheartj/ehx381
doi: 10.1093/eurheartj/ehx381
pubmed: 29020232
pmcid: 5837727
Weidemann F, Herrmann S, Störk S, Niemann M, Frantz S, Lange V et al (2009) Impact of mycardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120(7):577–584. https://doi.org/10.1161/CIRCULATIONAHA.108.847772
doi: 10.1161/CIRCULATIONAHA.108.847772
pubmed: 19652094